{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:40:06Z","timestamp":1749656406650,"version":"3.41.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2021\/11606-3","2021\/08260-8","2024\/07723-2","2023\/12246-6"],"award-info":[{"award-number":["2021\/11606-3","2021\/08260-8","2024\/07723-2","2023\/12246-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.htct.2025.103757","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T01:12:48Z","timestamp":1743815568000},"page":"103757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"47","author":[{"given":"Anali Del Milagro Bernabe","family":"Garnique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-4665","authenticated-orcid":false,"given":"Jorge Antonio Elias Godoy","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia Sudan","family":"Parducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-7787","authenticated-orcid":false,"given":"Mauricio Temotheo","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-534X","authenticated-orcid":false,"given":"Karoline de Barros","family":"Waitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keli","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia Veras","family":"Costa-Lotufo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9311-7245","authenticated-orcid":false,"given":"Roberto","family":"Parise-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-8109","authenticated-orcid":false,"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.htct.2025.103757_bib0001","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2025.103757_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686768","article-title":"BTK inhibitors in chronic lymphocytic leukemia: biological activity and immune effects","volume":"12","author":"Palma","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.htct.2025.103757_bib0003","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJMra1908213","article-title":"Treatment of chronic lymphocytic leukemia","volume":"383","author":"Burger","year":"2020","journal-title":"N Engl J Med"},{"issue":"69","key":"10.1016\/j.htct.2025.103757_bib0004","doi-asserted-by":"crossref","first-page":"33124","DOI":"10.18632\/oncotarget.26043","article-title":"Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia","volume":"9","author":"Huang","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.htct.2025.103757_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.htct.2025.103757_bib0006","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.htct.2025.103757_bib0007","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1200\/JCO.2017.76.6840","article-title":"Venetoclax for patients with chronic lymphocytic leukemia with 17p deletion: results from the full population of a phase II pivotal trial","volume":"36","author":"Stilgenbauer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.htct.2025.103757_bib0008","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.htct.2025.103757_bib0009","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.htct.2025.103757_bib0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4161\/15592294.2014.969628","article-title":"Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients","volume":"9","author":"Van Damme","year":"2014","journal-title":"Epigenetics"},{"issue":"16","key":"10.1016\/j.htct.2025.103757_bib0011","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.18632\/aging.103536","article-title":"Chidamide, a histone deacetylase inhibitor, inhibits autophagy and exhibits therapeutic implication in chronic lymphocytic leukemia","volume":"12","author":"Kong","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.htct.2025.103757_bib0012","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/blood-2002-12-3794","article-title":"Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein","volume":"102","author":"Aron","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.103757_bib0013","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.2147\/OTT.S170392","article-title":"Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia","volume":"11","author":"Ding","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.htct.2025.103757_bib0014","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2009.07881.x","article-title":"Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia","volume":"147","author":"Blum","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2025.103757_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115935","article-title":"HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents","volume":"263","author":"Waitman","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.htct.2025.103757_bib0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1875036201004010005","article-title":"Amazonia!: an online resource to google and visualize public human whole genome expression data","volume":"4","author":"Carrour","year":"2010","journal-title":"Open Bioinform J"},{"issue":"Pt B","key":"10.1016\/j.htct.2025.103757_bib0017","article-title":"Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia","volume":"311","author":"Lipreri da Silva","year":"2022","journal-title":"Life Sci"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:09:14Z","timestamp":1749654554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2531137925000252"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.103757","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.103757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103757"}}